InspireMD Inc (NSPR) - Net Assets
Based on the latest financial reports, InspireMD Inc (NSPR) has net assets worth $41.16 Million USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($44.64 Million) and total liabilities ($3.48 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check NSPR strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $41.16 Million |
| % of Total Assets | 92.2% |
| Annual Growth Rate | 84.4% |
| 5-Year Change | 64.62% |
| 10-Year Change | 1264.67% |
| Growth Volatility | 118.45 |
InspireMD Inc - Net Assets Trend (2008–2025)
This chart illustrates how InspireMD Inc's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see InspireMD Inc market capitalisation.
Annual Net Assets for InspireMD Inc (2008–2025)
The table below shows the annual net assets of InspireMD Inc from 2008 to 2025. Also explore InspireMD Inc net asset momentum to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $55.20 Million | +52.97% |
| 2024-12-31 | $36.09 Million | -8.65% |
| 2023-12-31 | $39.50 Million | +127.11% |
| 2022-12-31 | $17.39 Million | -48.13% |
| 2021-12-31 | $33.53 Million | +175.69% |
| 2020-12-31 | $12.16 Million | +125.95% |
| 2019-12-31 | $5.38 Million | -38.57% |
| 2018-12-31 | $8.76 Million | +221.34% |
| 2017-12-31 | $2.73 Million | -32.58% |
| 2016-12-31 | $4.04 Million | +237.30% |
| 2015-12-31 | $-2.95 Million | -5.71% |
| 2014-12-31 | $-2.79 Million | -151.44% |
| 2013-12-31 | $5.42 Million | +0.59% |
| 2012-12-31 | $5.39 Million | +0.07% |
| 2012-06-30 | $5.38 Million | -0.07% |
| 2011-12-31 | $5.39 Million | +234172.14% |
| 2010-12-31 | $-2.30K | 0.00% |
| 2009-12-31 | $-2.30K | -237.37% |
| 2008-12-31 | $1.68K | -- |
Equity Component Analysis
This analysis shows how different components contribute to InspireMD Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 30228117500.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $4.00K | 0.01% |
| Other Components | $357.49 Million | 647.61% |
| Total Equity | $55.20 Million | 100.00% |
InspireMD Inc Competitors by Market Cap
The table below lists competitors of InspireMD Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
XTI Aerospace, Inc.
NASDAQ:XTIA
|
$35.46 Million |
|
Baan Rock Garden Public Company Limited
BK:BROCK
|
$35.46 Million |
|
Wolford Aktiengesellschaft
VI:WOL
|
$35.47 Million |
|
Killi Resources Ltd
AU:KLI
|
$35.48 Million |
|
Sunfar Computer Co Ltd
TWO:6154
|
$35.45 Million |
|
Wooshin System
KO:017370
|
$35.44 Million |
|
DPS Resources Bhd
KLSE:7198
|
$35.44 Million |
|
HC Group Inc
STU:HCI
|
$35.44 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in InspireMD Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 36,086,000 to 55,201,000, a change of 19,115,000 (53.0%).
- Net loss of 48,786,000 reduced equity.
- New share issuances of 38,714,000 increased equity.
- Other factors increased equity by 29,187,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-48.79 Million | -88.38% |
| Share Issuances | $38.71 Million | +70.13% |
| Other Changes | $29.19 Million | +52.87% |
| Total Change | $- | 52.97% |
Book Value vs Market Value Analysis
This analysis compares InspireMD Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.01x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.00x to 1.01x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-12-31 | $307.34 | $0.76 | x |
| 2009-12-31 | $-328.71 | $0.76 | x |
| 2010-12-31 | $-328.71 | $0.76 | x |
| 2011-12-31 | $2821.37 | $0.76 | x |
| 2012-12-31 | $2821.37 | $0.76 | x |
| 2013-12-31 | $1727800.00 | $0.76 | x |
| 2014-12-31 | $-464500.00 | $0.76 | x |
| 2015-12-31 | $-267818.18 | $0.76 | x |
| 2016-12-31 | $72232.14 | $0.76 | x |
| 2017-12-31 | $1378.67 | $0.76 | x |
| 2018-12-31 | $284.80 | $0.76 | x |
| 2019-12-31 | $38.63 | $0.76 | x |
| 2020-12-31 | $8.04 | $0.76 | x |
| 2021-12-31 | $4.56 | $0.76 | x |
| 2022-12-31 | $2.21 | $0.76 | x |
| 2023-12-31 | $1.63 | $0.76 | x |
| 2024-12-31 | $0.86 | $0.76 | x |
| 2025-12-31 | $0.75 | $0.76 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently InspireMD Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -88.38%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -543.33%
- • Asset Turnover: 0.13x
- • Equity Multiplier: 1.26x
- Recent ROE (-88.38%) is above the historical average (-137.40%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | -228.36% | -0.11% | 692.59x | 2.94x | $-3.99K |
| 2009 | 0.00% | 0.00% | 0.00x | 0.00x | $-23.75K |
| 2010 | 0.00% | -0.48% | 832.77x | 0.00x | $-23.75K |
| 2011 | -326.72% | -328.98% | 0.33x | 2.97x | $-18.14 Million |
| 2012 | -326.72% | -328.98% | 0.33x | 2.97x | $-18.14 Million |
| 2013 | -338.67% | -600.41% | 0.23x | 2.40x | $-30.12 Million |
| 2014 | 0.00% | -890.53% | 0.25x | 0.00x | $-24.82 Million |
| 2015 | 0.00% | -674.68% | 0.40x | 0.00x | $-15.29 Million |
| 2016 | -209.17% | -446.73% | 0.20x | 2.33x | $-8.87 Million |
| 2017 | -309.42% | -305.61% | 0.45x | 2.24x | $-8.71 Million |
| 2018 | -82.62% | -201.06% | 0.29x | 1.40x | $-8.12 Million |
| 2019 | -186.51% | -269.82% | 0.38x | 1.84x | $-10.58 Million |
| 2020 | -86.69% | -424.31% | 0.14x | 1.46x | $-11.76 Million |
| 2021 | -44.49% | -331.88% | 0.11x | 1.18x | $-18.27 Million |
| 2022 | -106.31% | -357.59% | 0.21x | 1.42x | $-20.23 Million |
| 2023 | -50.42% | -320.97% | 0.13x | 1.21x | $-23.87 Million |
| 2024 | -88.69% | -456.63% | 0.15x | 1.30x | $-35.61 Million |
| 2025 | -88.38% | -543.33% | 0.13x | 1.26x | $-54.31 Million |
Industry Comparison
This section compares InspireMD Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $638,670,729
- Average return on equity (ROE) among peers: -85.75%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| InspireMD Inc (NSPR) | $41.16 Million | -228.36% | 0.08x | $35.46 Million |
| Abbott Laboratories (ABT) | $4.40 Billion | 38.41% | 1.14x | $177.76 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $12.40 Million | -202.26% | 2.49x | $11.55 Million |
| Aethlon Medical Inc (AEMD) | $-9.30 Million | 0.00% | 0.00x | $1.11 Million |
| Acutus Medical Inc (AFIB) | $-131.82 Million | 0.00% | 0.00x | $903.35K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $780.04 Million |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $1.53 Million | -361.86% | 1.36x | $4.88 Million |
| Allurion Technologies, Inc. (ALUR) | $-32.31 Million | 0.00% | 0.00x | $1.19 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $644.00K | -309.01% | 0.34x | $4.16 Million |
| Artivion Inc (AORT) | $79.80 Million | -34.79% | 0.33x | $1.16 Billion |
| Apyx Medical Inc (APYX) | $2.22 Million | 4.46% | 0.72x | $127.64 Million |
About InspireMD Inc
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard c… Read more